O2Cure

Blood Oxygenators and Respiratory Assist Devices

Health Tech & Life Sciences
Non Active, Jan 2022
Series B Tirat Carmel Founded 2013
Total raised
$6.6M
Last: Series B
Stage
Series B
Founded
2013
Headcount
5
HQ
Tirat Carmel
Sector
Health Tech & Life Sciences

About

O2Cure develops long-term blood oxygenators and respiratory assist devices using novel carbon nanotube technology and a unique design that enables efficient blood oxygenation with reduced harmful effect on blood in pumpless setups. O2Cure's technology is suitable for the development of long-term blood oxygenators and respiratory assist devices for use in hospitals, clinics, and at home.

Funding history · 1 round · $6.6M total

Date unknown
Series B $6.6M

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is O2Cure's primary focus in medical technology?
O2Cure develops long-term blood oxygenators and respiratory assist devices.
What core technology does O2Cure utilize for its devices?
O2Cure uses novel carbon nanotube technology and a unique design for efficient blood oxygenation.
When was O2Cure founded?
O2Cure was founded in May 2013.
What is the current operational status of O2Cure?
O2Cure is currently inactive, as of January 2022.
Where is O2Cure headquartered?
O2Cure is headquartered in Tirat Carmel, Israel.
What is the total amount of funding O2Cure has raised?
O2Cure has raised a total of $6.6 million in funding. For a full financing history, please refer to startupim.
What was O2Cure's last known funding round?
O2Cure's last known funding round was a Series B round, which raised $6.6 million from undisclosed investor(s).
How many employees does O2Cure have?
O2Cure has an employee count in the range of 1-10, with an exact count of 5 employees.
Who is a founder of O2Cure?
Yoram Palti is a founder of O2Cure.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesLife Support
Technologies
Materials & SubstancesNanomaterials
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B2C

Highlights

1 Patents

Tags

clinicsmedical-devicesnanotechnologyhospitalshome-carerespiratorypulmonary